Comparison of MagPix assays and enzyme-linked immunosorbent assay for detection of hemorrhagic fever viruses

Journal of Clinical Microbiology

Volumn 55, Issue 1, 2017, Pages 68-78

  Satterly, Neal G ^a,b   Voorhees, Matthew A ^a   Ames, Abbe D ^a   Schoepp, Randal J ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Ebola virus; ELISA; Immunoassays; Lassa virus; MagPix; Viral hemorrhagic fever

Indexed keywords

BUFFER; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIGEN; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ANIMAL CELL; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EBOLAVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LASSA VIRUS; LIMIT OF DETECTION; MAGPIX ASSAY; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SENSITIVITY ANALYSIS; VERO CELL LINE; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS LOAD; ANIMAL; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY; LASSA FEVER; PRIMATE; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN M; LASSA FEVER; LASSA VIRUS; MACACA MULATTA; PRIMATES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 85008312182     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01693-16     Document Type: Article

References (8)

1. Fichet-Calvet E, Rogers DJ. 2009. Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis 3:e388. https://doi.org/10.1371/journal.pntd.0000388.
2. MacNeil A, Rollin PE. 2012. Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Negl Trop Dis 6:e1546. https://doi.org/10.1371/journal.pntd.0001546.
3. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, McCormick JB. 1995. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 311:857-859. https://doi.org/10.1136/bmj.311.7009.857.
4. Casillas AM, Nyamathi AM, Sosa A, Wilder CL, Sands H. 2003. A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment. Biol Res Nurs 4:268-275. https://doi.org/10.1177/1099800403252603.
5. Richmond JK, Baglole DJ. 2003 Lassa fever: epidemiology, clinical features, and social consequences BMJ 327:1271-1275. https://doi.org/10.1136/bmj.327.7426.1271.
6. Peters CJ. 2005. Marburg and Ebola - arming ourselves against the deadly filoviruses. N Engl J Med 352:2571-2573. https://doi.org/10.1056/NEJMp058109.
7. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. 1999. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 179(Suppl 1): S192-S198. https://doi.org/10.1086/514313.
8. Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, Bajani MD, Peters CJ, Nichol ST. 2000. Genetic diversity among Lassa virus strains. JVirol 74:6992-7004. https://doi.org/10.1128/JVI.74.15.6992-7004.2000.